Application of self-assembly peptides targeting the mitochondria as a novel treatment for sorafenib-resistant hepatocellular carcinoma cells

Currently, there is no appropriate treatment option for patients with sorafenib-resistant hepatocellular carcinoma (HCC). Meanwhile, pronounced anticancer activities of newly-developed mitochondria-accumulating self-assembly peptides (Mito-FF) have been demonstrated. This study intended to determine...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Sci Rep
मुख्य लेखकों: Hong, Tae Ho, Jeena, M. T., Kim, Ok-Hee, Kim, Kee-Hwan, Choi, Ho Joong, Lee, Kyung Hee, Hong, Ha-Eun, Ryu, Ja-Hyoung, Kim, Say-June
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Nature Publishing Group UK 2021
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7806888/
https://ncbi.nlm.nih.gov/pubmed/33441650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-79536-z
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन